Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients

INTRODUCTION: No therapy has proven to be effective yet to reduce mortality and/or invasive mechanical ventilation (IMV) requirement in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. METHODS: We conducted a retrospective case-control study in the Nord F...

Descripción completa

Detalles Bibliográficos
Autores principales: Klopfenstein, Timothée, Zayet, Souheil, Lohse, Anne, Selles, Phillippe, Zahra, Hajer, Kadiane-Oussou, N’dri Juliette, Toko, Lynda, Royer, Pierre-Yves, Balblanc, Jean-Charles, Gendrin, Vincent, Conrozier, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423574/
https://www.ncbi.nlm.nih.gov/pubmed/32798660
http://dx.doi.org/10.1016/j.ijid.2020.08.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423574/
https://www.ncbi.nlm.nih.gov/pubmed/32798660
http://dx.doi.org/10.1016/j.ijid.2020.08.024

Ejemplares similares